Moxifloxacin-associated drug hypersensitivity syndrome with toxic epidermal necrolysis and fulminant hepatic failure.
Nori
Sarita
S
Nebesio
Chris
C
Brashear
Ryan
R
Travers
Jeffrey B
JB
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001372:Aza Compounds / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000150:complications / Q000209:etiology*; D017809:Fatal Outcome; D005260:Female; D024841:Fluoroquinolones; D006801:Humans; D017114:Liver Failure, Acute / Q000209:etiology*; D000077266:Moxifloxacin; D011804:Quinolines / Q000009:adverse effects*; D012140:Respiratory Tract Diseases / Q000188:drug therapy; D013262:Stevens-Johnson Syndrome / Q000209:etiology*
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin